Vasorelaxant effect of C16-PAF and C18-PAF on renal blood flow and systemic blood pressure in the anesthetized rat

Rajash K. Handa, Jack W. Strandhoy, Vardaman M. Buckalew

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

The renal vasoactive and systemic hypotensive effects of platelet activating factor (C16:0-PAF and C18:1-PAF) were examined in anesthetized male Wistar rats. Bolus injections of C16-PAF (0.5 - 25 ng/kg) and C18-PAF (2.5 - 200 ng/kg) into the arterial circulation of the kidney produced increases in renal blood flow (6 - 15%) before causing dose-dependant systemic hypotension (2 - 64 mmHg). The dose-response curves for renal blood flow and systemic blood pressure generated by intrarenal C18-PAF administration were approximately 7 fold to the right of the dose-response curves generated by C16-PAF. Intrarenal injections of vehicle or the biologically inactive enantiomer C16-DPAF (25 - 200 ng/kg) did not affect renal blood flow or systemic blood pressure. These results suggest that C16:0-PAF is a more potent renal vasodilator and hypotensive lipid than C18:1-PAF.

Original languageEnglish (US)
Pages (from-to)747-752
Number of pages6
JournalLife Sciences
Volume49
Issue number10
DOIs
StatePublished - 1991
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Vasorelaxant effect of C<sub>16</sub>-PAF and C<sub>18</sub>-PAF on renal blood flow and systemic blood pressure in the anesthetized rat'. Together they form a unique fingerprint.

  • Cite this